Traders Buy High Volume of Put Options on Baxter International (NYSE:BAX)

Baxter International Inc. (NYSE:BAXGet Free Report) was the recipient of unusually large options trading activity on Tuesday. Stock investors acquired 24,824 put options on the stock. This represents an increase of approximately 446% compared to the average volume of 4,550 put options.

Wall Street Analysts Forecast Growth

BAX has been the topic of several recent research reports. Citigroup lowered their price objective on shares of Baxter International from $44.00 to $38.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 22nd. TD Cowen cut shares of Baxter International from a “buy” rating to a “hold” rating and set a $40.00 price objective on the stock. in a research note on Friday, May 10th. Barclays increased their price objective on shares of Baxter International from $52.00 to $54.00 and gave the stock an “overweight” rating in a research note on Monday, February 12th. JPMorgan Chase & Co. increased their price objective on shares of Baxter International from $38.00 to $44.00 and gave the stock a “neutral” rating in a research note on Friday, February 9th. Finally, UBS Group lowered their price objective on shares of Baxter International from $40.00 to $36.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 6th. Nine research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $44.42.

View Our Latest Report on Baxter International

Institutional Investors Weigh In On Baxter International

Institutional investors and hedge funds have recently modified their holdings of the stock. Headinvest LLC bought a new stake in Baxter International in the third quarter worth $25,000. Bruce G. Allen Investments LLC bought a new stake in Baxter International in the fourth quarter worth $36,000. Turtle Creek Wealth Advisors LLC bought a new stake in Baxter International in the fourth quarter worth $37,000. Hexagon Capital Partners LLC increased its position in Baxter International by 205.4% in the fourth quarter. Hexagon Capital Partners LLC now owns 953 shares of the medical instruments supplier’s stock worth $37,000 after purchasing an additional 641 shares during the last quarter. Finally, LRI Investments LLC bought a new stake in Baxter International in the first quarter worth $39,000. Institutional investors own 90.19% of the company’s stock.

Baxter International Stock Performance

NYSE BAX traded down $0.23 on Tuesday, reaching $33.85. 647,194 shares of the stock were exchanged, compared to its average volume of 3,867,023. The firm has a market capitalization of $17.25 billion, a PE ratio of 6.55, a PEG ratio of 1.78 and a beta of 0.61. The company has a current ratio of 1.48, a quick ratio of 1.01 and a debt-to-equity ratio of 1.35. Baxter International has a one year low of $31.01 and a one year high of $50.21. The company’s 50-day simple moving average is $38.42 and its two-hundred day simple moving average is $39.06.

Baxter International (NYSE:BAXGet Free Report) last released its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.61 by $0.04. The firm had revenue of $3.59 billion for the quarter, compared to analysts’ expectations of $3.55 billion. Baxter International had a net margin of 17.79% and a return on equity of 18.47%. The company’s revenue for the quarter was down 1.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.59 earnings per share. Analysts expect that Baxter International will post 2.91 EPS for the current fiscal year.

Baxter International Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, July 1st. Stockholders of record on Friday, May 31st will be given a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a dividend yield of 3.43%. The ex-dividend date is Friday, May 31st. Baxter International’s payout ratio is currently 22.31%.

Baxter International Company Profile

(Get Free Report)

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.

Featured Articles

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.